Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 7/20 | 0.50 |
| ▸ | LGALS9 | O00182 | 6/20 | 0.50 |
| ▸ | LGALS1 | P09382 | 6/20 | 0.50 |
| ▸ | LGALS7; LGALS7B | P47929 | 5/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.40 |
| ▸ | SELP | P16109 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.34 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19481407 | 1.00 | LGALS3 (0.50) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL17636499 | 1.00 | LGALS3 (0.50) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL16588617 | 0.92 | LGALS9 (0.44) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL8271922 | 0.90 | LGALS9 (0.43) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL8271047 | 0.90 | LGALS9 (0.43) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL16326716 | 0.90 | LGALS9 (0.43) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL17636482 | 0.88 | LGALS9 (0.43) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL16581558 | 0.87 | LGALS9 (0.51) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL18239534 | 0.86 | LGALS9 (0.40) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 | |
| SCHEMBL12848097 | 0.86 | LGALS9 (0.55) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160279224-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2016-09-29 | — | — | US | disclosed |
| WO-2015040140-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-03-26 | — | — | WO | disclosed |
| EP-2851092-A1 | Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160279224-A1 | PROTEIN AND PEPTIDE-FREE SYNTHETIC VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE TYPE 3 | STT3A, DDOST, LGALS3BP | LGALS3 9/4885LGALS9 75/4885LGALS1 67/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.